Can one pivotal trial secure FDA approval? Operation TrialBlazer reshapes biotech development
The FDA is clarifying when one rigorous pivotal trial supported by confirmatory evidence may establish a drug’s effectiveness. The approach could shorten development in rare diseases and precision medicine, but it does not turn small, uncontrolled or statistically fragile studies into approval-ready evidence.